
- GMP
About
iProgen is a biotechnology company based in Vancouver, British Columbia, and Burnaby, Canada. It develops antibody drug conjugate and protein delivery technologies and works with academic and industry partners on therapeutic programs. The company says it focuses on non-oncology therapeutics as well as oncology, using its Smart Antibodies platform and related payload-conjugation technologies.
Services
Antibody drug conjugate discovery
Develops next-generation antibody drug conjugate approaches using Smart Antibodies and diverse payloads.
Protein delivery technology development
Creates and applies intracellular and conditionally activated protein delivery technologies for therapeutic programs.
Antibody internalization technology licensing
Out-licenses antibody internalization technologies for delivery applications.
Antibody-oligonucleotide conjugate technology licensing
Out-licenses technologies for antibody-oligonucleotide conjugate applications.
Degrader antibody conjugate technology licensing
Out-licenses modular degrader antibody conjugate technology.
Research collaboration
Works with academic and industry partners to design antibody drug candidates, perform preliminary in-vitro evaluations, and advance collaborative programs.
Antibody and ADC assay development
Develops assays for antibody and ADC research programs.
Assays & in vitro testing
Cell line development
Provides cell line development expertise for research and development projects.
Cell line development
Recombinant protein production
Supports recombinant protein production, including cGMP-related work and characterization.
Protein production
Capabilities
- Assays and studies
- Antibodies · ADCs · Small molecules · Peptides · Oligonucleotides · In-vitro evaluations · In-vivo evaluations · Antibody assay development · ADC assay development · Preliminary in-vitro evaluations
- Therapeutic areas
- Oncology · Sarcopenia · Neurodegenerative · Osteoporosis · Non-oncology therapeutics
Modalities and species
- Modalities
- Small molecule · Antibody · ADC · Peptide · Oligonucleotide · Recombinant protein · Vaccine
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Industries served
- Biotech
- Therapeutic research
Locations
- Based in
- Burnaby, BC, Canada
- Sites
- Vancouver, Canada · Burnaby, Canada
- Serves
- global
Contacts
- General enquiry
- info@iprogen.com on their site
- Phone
- 604-428-4978
Similar labs
Work here? Claim this listing